Sanofi reported EUR12.3B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
AbbVie USD 17.4B 410M Sep/2026
Amgen USD 10.4B 300M Sep/2026
AstraZeneca USD 16.21B 830M Sep/2026
Bristol-Myers Squibb USD 13.07B 100M Sep/2026
Canopy Growth CAD 81.16M 9.91M Jun/2026
Corcept Therapeutics USD 340.5M 84.35M Sep/2026
Drreddys Laboratories INR 86.71B 85.92B Sep/2026
Eli Lilly USD 24.4B 1.43B Sep/2026
Genmab DKK 1.16B 259M Jun/2026
GlaxoSmithKline GBP 8.89B 480M Sep/2026
Glaxosmithkline GBP 8.89B 1.2B Sep/2026
J&J USD 25.4B 89M Sep/2026
Lakefront Biotherapeutics EUR 7.11M 5M Sep/2026
Merck USD 18.1B 1.5B Sep/2026
Novartis USD 14.52B 112M Sep/2026
Novartis USD 15.03B 1.92B Sep/2026
Pacira USD 176.65M 15.75M Sep/2026
Perrigo USD 989M 31M Sep/2026
Pfizer USD 16.6B 1.57B Sep/2026
Phibro Animal Health USD 373.91M 10.02M Dec/2025
Prestige Brands USD 265.71M 15.91M Jun/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Sanofi EUR 14.44B 2.49B Sep/2026
Sanofi EUR 12.3B 160M Jun/2026
Supernus Pharmaceuticals USD 226.8M 7.7M Sep/2026
UCB EUR 4.25B 764M Dec/2025
Zoetis USD 2.4B 100M Sep/2026